Drug General Information |
Drug ID |
D09AYR
|
Former ID |
DNC003474
|
Drug Name |
3,5-Dinitrocatechol
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C6H4N2O6
|
Canonical SMILES |
C1=C(C=C(C(=C1[N+](=O)[O-])O)O)[N+](=O)[O-]
|
InChI |
1S/C6H4N2O6/c9-5-2-3(7(11)12)1-4(6(5)10)8(13)14/h1-2,9-10H
|
InChIKey |
VDCDWNDTNSWDFJ-UHFFFAOYSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
3288986, 5656640, 7887114, 8150015, 9995719, 11111032, 11113526, 11335242, 11360481, 11363081, 11365643, 11368205, 11374213, 11376367, 11461453, 11484954, 11488925, 11492562, 11494001, 15092170, 17405040, 24278158, 26612504, 26679507, 26712257, 26747113, 41950019, 46507481, 48034943, 48184833, 48259055, 49746560, 49746563, 49879920, 50104432, 50104433, 53777583, 53787185, 56463318, 57356617, 58021763, 79675931, 85085622, 85230992, 88565526, 90341310, 92303738, 99301155, 99309283, 103424770
|
Target and Pathway |
Target(s) |
Catechol-O-methyl-transferase |
Target Info |
Inhibitor |
[1]
|
BioCyc Pathway
|
L-dopa degradation
|
Dopamine degradation
|
Noradrenaline and adrenaline degradation
|
KEGG Pathway
|
Steroid hormone biosynthesis
|
Tyrosine metabolism
|
Metabolic pathways
|
Dopaminergic synapse
|
PANTHER Pathway
|
Adrenaline and noradrenaline biosynthesis
|
Dopamine receptor mediated signaling pathway
|
PathWhiz Pathway
|
Tyrosine Metabolism
|
WikiPathways
|
Methylation Pathways
|
Metapathway biotransformation
|
Estrogen metabolism
|
Biogenic Amine Synthesis
|
Dopamine metabolism
|
Phase II conjugation
|
Neurotransmitter Clearance In The Synaptic Cleft
|
References |
REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |